Catch up on the top radiology content of the past week.
|Articles|October 28, 1998
Life Imaging gets $3 million infusion
Three-dimensional ultrasound developer Life Imaging Systems has received a $3 million (Canadian) private placement from a Canadian investment firm. The cash infusion is part of a total investment of $8 million made in Life by Sofinov, Societé
Advertisement
Three-dimensional ultrasound developer Life Imaging Systems has received a $3 million (Canadian) private placement from a Canadian investment firm. The cash infusion is part of a total investment of $8 million made in Life by Sofinov, Societé financière dinnovation, of Montreal, Quebec.
Life plans to use the money for product commercialization and market expansion purposes, according to the company. Life, of London, Ontario, recently assembled a marketing team and developed a new corporate identity. It plans to display its products at this years Radiological Society of North America meeting.
Lifes L3D family of products are targeted at ultrasound OEMs and enable users to assemble 3-D ultrasound images from 2-D scans.
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
4
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
5